Cormorant Asset Management, LP

(See below) at ENVIVIO INC · on record since Jun 8, 2023
10% owner at EyePoint, Inc. · on record since Dec 12, 2023
10% owner at MoonLake Immunotherapeutics · on record since Oct 10, 2023
10% owner at Corbus Pharmaceuticals Holdings, Inc. · on record since Jan 30, 2024
10% owner at BioAge Labs, Inc. · on record since Sep 25, 2024
10% owner at OnKure Therapeutics, Inc. · on record since Oct 15, 2024
Former 10% Owner at BioAge Labs, Inc. · on record since Oct 1, 2024
Former 10% Owner at NEXCORE HEALTHCARE CAPITAL CORP · on record since Feb 19, 2025
10% owner at NEXCORE HEALTHCARE CAPITAL CORP · on record since Feb 12, 2025
Former 10% Owner at OnKure Therapeutics, Inc. · on record since May 19, 2025
Former 10% Holder at Biomea Fusion, Inc. · on record since Aug 1, 2025
Former 10% Owner at EyePoint, Inc. · on record since Dec 8, 2025
Former 10% Owner at MoonLake Immunotherapeutics · on record since Oct 1, 2025
10% owner at Elevate, Inc. · on record since Jun 24, 2021
10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 23, 2021
Former 10% Owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
10% owner at Tyra Biosciences, Inc. · on record since Sep 14, 2021
10% owner at Biomea Fusion, Inc. · on record since Apr 22, 2021
10% owner at · on record since Apr 22, 2021
Former 10% Owner at · on record since Apr 30, 2026
Director at · on record since Apr 19, 2021
10% owner at · on record since Nov 23, 2016
10% owner at · on record since Jun 16, 2021
10% owner at · on record since Sep 5, 2014
10% owner at · on record since Jun 13, 2016
10% owner at · on record since Aug 6, 2026
10% owner at · on record since Nov 14, 2017
10% owner at · on record since May 31, 2018
10% owner at · on record since Jun 27, 2018
10% owner at · on record since Jul 20, 2018
10% owner at · on record since Oct 30, 2018
Former 10% Owner at · on record since Apr 1, 2021
10% owner at · on record since Apr 25, 2019
Former 10% Owner at · on record since Aug 12, 2019
10% owner at · on record since Jun 25, 2020
Former 10% Owner at · on record since Jun 18, 2020
10% owner at · on record since Jun 11, 2020
Former 10% Owner at · on record since Jul 2, 2020
10% owner at · on record since Oct 29, 2020
Former 10% Owner at · on record since Nov 23, 2020
Former 10% Owner at · on record since Dec 22, 2020
10% owner at · on record since Nov 18, 2020
10% owner at · on record since Dec 15, 2020
Former 10% Owner at · on record since Nov 5, 2020
10% owner at · on record since Mar 25, 2021
10% owner at · on record since Mar 18, 2021
Former 10% Owner at · on record since Mar 18, 2021
Former 10% Owner at · on record since Jun 30, 2021
10% owner at · on record since Jun 29, 2021
Former 10% Owner at · on record since Apr 29, 2021
10% owner at · on record since Jul 28, 2021
10% owner at · on record since Jul 22, 2021
Former 10% Owner at · on record since Sep 21, 2021
Former 10% Owner at · on record since Jul 7, 2021
Former 10% Owner at · on record since Aug 5, 2021
Former 10% Owner at · on record since Aug 4, 2021
Former 10% Owner at · on record since Jul 1, 2021
Former 10% Owner at · on record since Oct 27, 2021
10% owner at · on record since Oct 20, 2021
Former 10% Owner at · on record since Oct 15, 2021
10% owner at · on record since Oct 7, 2021
Former 10% Owner at · on record since Jan 13, 2022
10% owner at · on record since Jan 6, 2022
Director at · on record since Dec 21, 2022
10% owner at · on record since Mar 16, 2023
10% owner at · on record since Oct 17, 2024
10% owner at · on record since Jul 29, 2021

Insider trading activity of Cormorant Asset Management, LP

Transactions on record: 53; since Nov 14, 2016

Open-market buys: 24; $171.8M

Open-market sells: 2; $10.7M

Companies traded: 15; last filing Apr 30, 2026

Figures computed from official regulatory filings — .

Companies where Cormorant Asset Management, LP has traded

2 tx · $13.8M · Apr 30, 2026
6 tx · $38.1M · Dec 8, 2025
1 tx · $14.3M · Feb 6, 2024
1 tx · $9.1M · Oct 25, 2023
2 tx · $19.6M · Sep 19, 2023
7 tx · $19.2M · Dec 21, 2022
4 tx · $15.3M · Jun 24, 2022
3 tx · $7.2M · Oct 15, 2021
3 tx · $8.3M · Aug 5, 2021
4 tx · $11.4M · Jun 30, 2021
4 tx · $15M · Apr 1, 2021
6 tx · Nov 5, 2020
3 tx · $7.3M · May 16, 2019
3 tx · $1.2M · May 31, 2018

Track record of Cormorant Asset Management, LP

Statistical track record

Free account

Open-market buys: 24

Last buy: Nov 4, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Cormorant Asset Management, LP

Co-insiders of Cormorant Asset Management, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Apr 30, 2026	Sell	-109,331	89.50 USD	$9.8M		SEC
EyePoint, Inc.Listing on record	Dec 8, 2025	Sell	-60,000	15.70 USD	$942K		SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Nov 6, 2024	Buy	184,331	21.70 USD	$4M	conv 33	SEC
EyePoint, Inc.Listing on record	May 8, 2024	Buy	207,153	12.36 USD	$2.6M	conv 31	SEC
EyePoint, Inc.Listing on record	May 8, 2024	Buy	642,847	11.70 USD	$7.5M	conv 33	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Feb 6, 2024	Buy	750,000	19.00 USD	$14.3M	conv 51	SEC
EyePoint, Inc.Listing on record	Jan 11, 2024	Buy	105,000	21.32 USD	$2.2M	conv 17	SEC
EyePoint, Inc.Listing on record	Jan 11, 2024	Buy	750,000	19.75 USD	$14.8M	conv 31	SEC
EyePoint, Inc.Listing on record	Dec 12, 2023	Buy	588,235	17.00 USD	$10M	conv 25	SEC
Ambrx Biopharma, Inc.Listing unverified	Oct 25, 2023	Buy	1,307,311	6.99 USD	$9.1M	conv 29	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Sep 19, 2023	Buy	1,401,505	9.05 USD	$12.7M	conv 36	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Sep 19, 2023	Buy	751,233	9.24 USD	$6.9M	conv 20	SEC
Erasca, Inc.Listing on record	Dec 21, 2022	Buy	307,692	6.50 USD	$2M	conv 37First in 12mo	SEC
Erasca, Inc.Listing on record	Dec 20, 2022	Buy	307,692	6.50 USD	$2M	conv 37First in 12mo	SEC
Biomea Fusion, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	23,867	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	OtherD (derivative)	-668,854	—	n/a (No price was disclosed in the filing)		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	Other	668,854	—	n/a (No price was disclosed in the filing)		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	Buy	450,000	16.00 USD	$7.2M	conv 33	SEC
Immuneering CorpListing on record	Aug 5, 2021	OtherD (derivative)	-1,702,628	—	n/a (No price was disclosed in the filing)		SEC
Immuneering CorpListing on record	Aug 5, 2021	Buy	550,000	15.00 USD	$8.3M	conv 37Cluster	SEC
Immuneering CorpListing on record	Aug 5, 2021	Other	1,702,628	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	4,000,000	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	Other	9,555,553	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	4,166,666	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	1,388,887	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Apr 30, 2026	Sell	-109,331	89.50 USD	$9.8M		SEC
EyePoint, Inc.Listing on record	Dec 8, 2025	Sell	-60,000	15.70 USD	$942K		SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Nov 6, 2024	Buy	184,331	21.70 USD	$4M	conv 33	SEC
EyePoint, Inc.Listing on record	May 8, 2024	Buy	207,153	12.36 USD	$2.6M	conv 31	SEC
EyePoint, Inc.Listing on record	May 8, 2024	Buy	642,847	11.70 USD	$7.5M	conv 33	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Feb 6, 2024	Buy	750,000	19.00 USD	$14.3M	conv 51	SEC
EyePoint, Inc.Listing on record	Jan 11, 2024	Buy	105,000	21.32 USD	$2.2M	conv 17	SEC
EyePoint, Inc.Listing on record	Jan 11, 2024	Buy	750,000	19.75 USD	$14.8M	conv 31	SEC
EyePoint, Inc.Listing on record	Dec 12, 2023	Buy	588,235	17.00 USD	$10M	conv 25	SEC
Ambrx Biopharma, Inc.Listing unverified	Oct 25, 2023	Buy	1,307,311	6.99 USD	$9.1M	conv 29	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Sep 19, 2023	Buy	1,401,505	9.05 USD	$12.7M	conv 36	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Sep 19, 2023	Buy	751,233	9.24 USD	$6.9M	conv 20	SEC
Erasca, Inc.Listing on record	Dec 21, 2022	Buy	307,692	6.50 USD	$2M	conv 37First in 12mo	SEC
Erasca, Inc.Listing on record	Dec 20, 2022	Buy	307,692	6.50 USD	$2M	conv 37First in 12mo	SEC
Biomea Fusion, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	23,867	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	OtherD (derivative)	-668,854	—	n/a (No price was disclosed in the filing)		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	Other	668,854	—	n/a (No price was disclosed in the filing)		SEC
Pyxis Oncology, Inc.Listing on record	Oct 15, 2021	Buy	450,000	16.00 USD	$7.2M	conv 33	SEC
Immuneering CorpListing on record	Aug 5, 2021	OtherD (derivative)	-1,702,628	—	n/a (No price was disclosed in the filing)		SEC
Immuneering CorpListing on record	Aug 5, 2021	Buy	550,000	15.00 USD	$8.3M	conv 37Cluster	SEC
Immuneering CorpListing on record	Aug 5, 2021	Other	1,702,628	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	4,000,000	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	Other	9,555,553	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	4,166,666	—	n/a (No price was disclosed in the filing)		SEC
Erasca, Inc.Listing on record	Jul 22, 2021	OtherD (derivative)	1,388,887	—	n/a (No price was disclosed in the filing)		SEC